Introduction. Cholinergic mechanisms play an important role in the control of hormonal and vascular regulation. However, in utero development of cholinergic regulation in the foetal hormonal systems is not clearly understood.This study investigated foetal hormonal and cardiovascular responses following application of the muscarinic antagonist atropine.
Materials and methods. Chronically prepared near-term ovine foetuses (control and experimental: n=5, each group) were used.After 4—5 days’ surgical recovery, conscious ewes and their foetuses were tested in vivo.
Results. In response to intravenous atropine, foetal systolic, diastolic, and mean arterial pressure, as well as heart rate, increased immediately. Inhibition of muscarinic systems in the circulation caused a reduction of plasma angiotensin II levels, while angiotensin I in the circulation remained unchanged in the foetus. In addition, foetal plasma aldosterone levels were significantly increased following blockade of the cholinergic receptor, while other hormones, including arginine vasopressin, adrenocorticotrophic hormone, and atrial natriuretic peptide, were not changed in foetal blood under the same condition.
Conclusions. The results suggest that foetal automatic systems, not those hormonal factors tested, play a major role in cholinergic mechanisms mediating cardiovascular control. Furthermore, the data provide new information on how muscarinic inhibition affects renin-angiotensin system and adrenal cortex functions. Key words: aldosterone, angiotensin-converting enzyme, autonomic regulation, foetus
Slotkin TAFetal nicotine or cocaine exposure: which one is worse?Pharmacol Exp Ther1998;285:931-45.
2.
Yuan H., Platt RW, Morin L., Joseph KS, Kramer MSFetal deaths in the United States, 1997 vs 1991. Am J Obstet Gynecol2005;193:489-95.
3.
Zdravkovic T. , Genbacev O., McMaster MT, Fisher SJThe adverse effects of maternal smoking on the human placenta: a review. Placenta2005 ;26(suppl A):S81-6.
4.
Lee SB, Kim SY, Sung KWCardiovascular regulation by cholinergic mechanisms in rostral ventrolateral medulla of spontaneously hypertensive rats. Eur J Pharmacol1991;205:117-23.
5.
Sommers DK, Meyer EC, van Wyk M.The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man. Eur J Clin Pharmacol1990;38:401-03.
6.
Jánossy A., Orsó E., Szalay KS et al. Cholinergic regulation of the rat adrenal zona glomerulosa. J Endocrinol1998;157:305-15.
7.
Poller U., Nedelka G., Radke J., Pönicke K., Brodde OEAge-dependent changes in cardiac muscarinic receptor function in healthy volunteers . J Am Coll Cardiol1997;29:187-93.
8.
Lindh B., Hokfelt T.Structural and functional aspects of acetylcholine peptide coexistence in the autonomic nervous system. Prog Brain Res1990;84:175-91.
9.
De Groat WC, Booth AMInhibition and facilitation in parasympathetic ganglia of the urinary bladder . Fed Proc1980;39:2990-6.
10.
Iwasaki K., Zhang R., Zuckerman JH, Levine BDDose-response relationship of the cardiovascular adaptation to endurance training in healthy adults: how much training for what benefit?J Appl Physiol2003;95:1575-83.
11.
Galanter CA , Wasserman G., Sloan RP, Pine DSChanges in autonomic regulation with age: implications for psychopharmacologic treatments in children and adolescents . J Child Adolesc Psychopharmacol1999; 9:257-65.
12.
Terzolo M., Matrella C., Boccuzzi A. et al. Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features. J Endocrinol Invest1999;22:48-54.
13.
Oświecimska J., Ziora K., Adamczyk P. et al. Effects of neuroendocrine changes on results of ambulatory blood pressure monitoring (ABPM) in adolescent girls with anorexia nervosa. Neuro Endocrinol Lett2007;28:410-16.
14.
Rademaker MT , Charles CJ, Espiner EA et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol2002;40:1495-505.
15.
Shi L., Yao J., Koos BJ, Xu Z.Induced fetal depressor or pressor responses associated with c-fos by intravenous or intracerebroventricular losartan. Dev Brain Res2004; 153:53-60.
16.
Xu Z., Glenda C., Day L., Yao J., Ross MGCentral angiotensin induction of fetal brain c-fos expression and swallowing activity. Am J Physiol Regul Integr Comp Physiol2001; 280:R1837-43.
17.
Xu Z., Nijland MJ, Ross MGPlasma osmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatr Res2001;49:678-85.
18.
Naguib M., Gomaa M.Atropine-neostigmine mixture: a dose-response study. Can J Anaesth1989;6:412-17.
19.
Brezenoff HE , Giuliano R.Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol1982;22:341-81.
20.
Barbosa SP, de Gobbi JI, Zilioli L. et al. Role of cholinergic and adrenergic pathways of the medial septal area in the water intake and pressor response to central angiotensin II and carbachol in rats. Brain Res Bull1995;37:463-6.
21.
Harding JW, Jensen LL, Quirk WS, Dewey AL, Wright JWBrain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function. Peptides1989 ;10:261-4.
22.
Breen S., Rees S., Walker D.Identification of brainstem neurons responding to hypoxia in fetal and newborn sheep. Brain Res1997;748:107-21.
23.
Ali-Melkkila T., Kanto J., Iisalo E.Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand1993;37:633-42.
24.
Lazartigues E., Brefel-Courbon C., Tran MA, Montastruc JL, Rascol O.Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms. Br J Pharmacol1999;127:1657-65.
25.
Saito R., Kamiya HO, Ono N.Role of the central muscarinic receptor of prostaglandin I2 in cardiovascular function in rat. Brain Res1985;330:167-9.
26.
Kinney HC, O’Donnell TJ, Kriger P., White WFEarly developmental changes in [3H]nicotine binding in the human brainstem . Neuroscience1993;55:1127-38.
27.
Kinney HC, Panigrahy A., Rava LA, White WFThree-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem. J Comp Neurol1995;362:350-67.
28.
Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A.Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?J Hypertens2003;21:1429-43.
29.
Pratt REAngiotensin II and the control of cardiovascular structure. J Am Soc Nephrol1999;10(suppl 11):120-8.
30.
Riegger GA, Albert M., Kochsiek K.Cardiovascular effects of AVP and ANG in experimental pulmonic stenosis in rats. Am J Physiol1988;254:H438-42.
31.
Reid IAInteractions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol1992;262:E763-78.
32.
Guillery EN , Robillard JEThe renin-angiotensin system and blood pressure regulation during infancy and childhood. Pediatr Clin North Am1993; 40:61-79.
33.
Hall JEThe renin-angiotensin system: renal actions and blood pressure regulation . Compr Ther1991;17:8-17.
34.
Mitsui T., Nomura S., Itakura A., Mizutani S.Role of aminopeptidases in the blood pressure regulation. Biol Pharm Bull2004;27:768-71.
35.
Scott BB, McGeehan GM, Harrison RKDevelopment of inhibitors of the aspartyl protease renin for the treatment of hypertension. Curr Protein Pept Sci2006 ; 7:241-54.
36.
Ondetti MA, Rubin B., Cushman DWDesign of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science1977; 196:441-4.
37.
Young MJ, Funder JWMineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens2002 ;20:1465-8.
38.
Fuller PJAldosterone and its mechanism of action: more questions than answers . Aust N Z J Med1995; 25:800-07.
39.
Johnston CI , Hodsman PG, Kohzuki M., Casley DJ, Fabris B., Phillips PAInteraction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med1989;87:24S-28S.
